There is no generic version of Opzelura (ruxolitinib cream) currently available.
What is Opzelura used for?
Opzelura is a prescription medication used to treat atopic dermatitis (eczema) in non-bullous plaque plaque-type psoriasis in individuals 12 years of age and older who have had an inadequate response to topical therapies. It is also approved for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. [1]
When does Opzelura's patent expire?
The U.S. Food and Drug Administration (FDA) approved Opzelura, developed by Incyte, in September 2021. As of late 2023, the exact patent expiry dates for Opzelura are not publicly available. Patent information for pharmaceuticals can be complex and may involve multiple patents covering different aspects of the drug, such as its composition, manufacturing, and methods of use. Information on drug patents and exclusivity periods can often be found through specialized resources like DrugPatentWatch.com [2].
Can a generic version be developed?
A generic version of Opzelura can only be developed and approved by the FDA after the relevant patents and exclusivities expire. Once these protections lapse, other pharmaceutical companies can apply to manufacture and market generic versions of the drug, which are typically bioequivalent to the branded product.
What is the active ingredient in Opzelura?
The active ingredient in Opzelura is ruxolitinib. [1] Ruxolitinib is a Janus kinase (JAK) inhibitor.
How does Opzelura work?
Opzelura works by inhibiting Janus kinase enzymes, which are involved in the signaling pathways that contribute to inflammation and immune responses in skin conditions like atopic dermatitis and psoriasis. By blocking these pathways, ruxolitinib helps to reduce itching and inflammation associated with these conditions. [1]
What are the potential side effects of Opzelura?
Common side effects of Opzelura include upper respiratory tract infections, ear infections, acne, and itching. Serious side effects can include a risk of serious infections, increased risk of certain cancers, major cardiovascular events, blood clots, and stroke. [1]
Are there other treatments for atopic dermatitis and psoriasis?
Yes, there are other treatment options for atopic dermatitis and psoriasis, which can include topical corticosteroids, calcineurin inhibitors, PDE4 inhibitors, and biologic agents, depending on the severity and specific characteristics of the condition.
Sources:
1. https://www.opzelura.com/
2. https://drugpatentwatch.com/